type in your search and press enter
You May Also Like
UroGen Pharma Announces FDA Acceptance of Investigational New Drug Application for MitoGel, a Novel Sustained Release Formulation of Mitomycin C, for the Treatment of Low-Grade Upper Tract Urothelial Carcinoma
RA’ANANA, Israel and NEW YORK, Dec. 12, 2016 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd., ...
Adaptimmune Reports First Quarter 2017 Financial Results
– Offerings in March and April raised net proceeds of $103.2 million; operations funded ...
La Jolla Pharmaceutical Company Announces FDA Approval of Giapreza™ (angiotensin II)
Giapreza increases blood pressure in adults with septic or other distributive shock La Jolla ...